Thomas Steyer’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,800
Closed -$234K 134
2026
Q1
$234K Sell
2,800
-2,200
-44% -$181K ﹤0.01% 132
2025
Q4
$458K Hold
5,000
﹤0.01% 98
2025
Q3
$474K Sell
5,000
-314,800
-98% -$29.6M ﹤0.01% 94
2025
Q2
$33.5M Sell
319,800
-102,000
-24% -$9.67M 0.14% 61
2025
Q1
$37.3M Buy
421,800
+419,000
+14,964% +$43M 0.18% 63
2024
Q4
$269K Hold
2,800
﹤0.01% 118
2024
Q3
$229K Hold
2,800
﹤0.01% 137
2024
Q2
$241K Hold
2,800
﹤0.01% 126
2024
Q1
$229K Buy
+2,800
New +$219K ﹤0.01% 143
2023
Q4
Sell
-2,800
Closed -$205K 164
2023
Q3
$205K Buy
+2,800
New +$189K ﹤0.01% 127

Other funds holding HQY

Thomas Steyer's HQY Position: Q2 2026 in Review

Thomas Steyer sold out of HealthEquity (HQY) in Q2 2026, closing a stake of 2,800 shares — an estimated $234K sold.

Thomas Steyer first reported a position in HQY in Q3 2023 and held it in 10 quarters. The position peaked at $37.3M in Q1 2025. 495 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

  • Thomas Steyer reported no remaining HealthEquity position as of Q2 2026 after selling out during the quarter.
  • Thomas Steyer sold 2,800 HealthEquity shares in Q2 2026, an estimated $234K.
  • Thomas Steyer first reported a position in HealthEquity in Q3 2023 and held it in 10 quarters.
  • Thomas Steyer's HealthEquity position peaked at $37.3M in Q1 2025.
  • 495 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on Farallon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.